Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis: Forms of pediatric diabetes
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To test the hypothesis that anti-islet autoantibody expression and random serum C-peptide obtained at diagnosis define phenotypes of pediatric diabetes with distinct clinical features. SUBJECTS: We analyzed 607 children aged <19 yr consecutively diagnosed with diabetes after exclusion of 13% of cases with secondary diabetes (e.g., cystic fibrosis related, steroid induced) and 7.3% of cases lacking measurement of C-peptide and/or autoantibodies. METHODS: Autoantibody positivity (A+) was defined as ≥ 1 positive out of GAD65, insulin, and ICA512 antibodies. Preserved beta-cell function (β+) was defined as random serum C-peptide at diagnosis ≥ 0.6 ng/mL. Body mass index (BMI) was measured at median 1.2 months after diagnosis. Characteristics at diagnosis and 2 yr (range 18-30 months) after diagnosis were compared among groups. RESULTS: Autoantibody expression and C-peptide at diagnosis defined the following groups: A+β- (52.1% of the children), A+β+ (32.8%), A-β+ (12.5%), and A-β- (2.6%). These four groups differed in gender, race/ethnicity, and clinical characteristics at diagnosis [i.e., age, pubertal development, obesity/overweight, diabetic ketoacidosis, glycemia, and hemoglobin A1c (HbA1c)] and at 2 yr (i.e., clinical diagnosis, treatment, and HbA1c) (all p < 0.0001). Among all β+ children, C-peptide >2 ng/mL was associated with lower HbA1c at onset (p = 0.0001) and, in the A+β+ subgroup, with higher frequency of achieving HbA1c < 7% at 2 yr (p = 0.03). All three patients (0.7% of total) with monogenic diabetes (maturity onset diabetes of the young, MODY) were A-β+ with C-peptide between 0.6 and 2 ng/mL. CONCLUSIONS: Anti-islet autoantibodies status and serum random C-peptide at diagnosis define four distinct phenotypes of pediatric diabetes with prognostic value.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SEARCH for Diabetes in Youth Study Group (2006) · Pediatrics · doi:10.1542/peds.2006-0690 · Cited by 726
The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes
Wilkin, T. J. (2001) · Diabetologia · doi:10.1007/s001250100548 · Cited by 623 · cited 1×
“It is possible that these children, who have anti-islet autoimmunity but present with greater beta-cell function than A+β− children, were diagnosed at an earlier stage of betacell destruction because of the co-existence of insulin resistance, as proposed by the ‘accelerator hypothesis’ (14).”
Background(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-7-199804010-00001 · Cited by 546
Keenan, H. A., Sun, J. K., Levine, J., Doria, A., Aiello, L. P., Eisenbarth, G., Bonner-Weir, S., & King, G. L. (2010) · Diabetes · doi:10.2337/db10-0676 · Cited by 500
Palmer, J. P., Fleming, G. A., Greenbaum, C. J., Herold, K. C., Jansa, L. D., Kolb, H., Lachin, J. M., Polonsky, K. S., Pozzilli, P., Skyler, J. S., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.1.250 · Cited by 491
Accuracy and predictive value of classification schemes for ketosis-prone diabetes
Balasubramanyam, A., Garza, G., Rodriguez, L., Hampe, C. S., Gaur, L., Lernmark, A., & Maldonado, M. R. (2006) · Diabetes Care · doi:10.2337/dc06-0749 · Cited by 166
Self-citation
Cited by
Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome
Punthakee, Z., Goldenberg, R., & Katz, P. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.003 · Cited by 877
Chiang, J. L., Maahs, D. M., Garvey, K. C., Hood, K. K., Laffel, L. M., Weinzimer, S. A., Wolfsdorf, J. I., & Schatz, D. (2018) · Diabetes Care · doi:10.2337/dci18-0023 · Cited by 509
Shepherd, M., Shields, B., Hammersley, S., Hudson, M., McDonald, T. J., Colclough, K., Oram, R. A., Knight, B., Hyde, C., Cox, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0645 · Cited by 236
“Other smaller studies (4, 8, 20-22) report screening or assessment of single pediatric clinic populations and although islet autoantibody negativity is often used to identify children who could benefit from genetic testing the screening and testing strategies are variable with estimates of prevalence up to 2.”
BackgroundRedondo, M. J., Steck, A. K., & Pugliese, A. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12597 · Cited by 216
Self-citationIqbal, S., Jayyab, A. A., Alrashdi, A. M., & Reverté-Villarroya, S. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.01.004 · Cited by 27
Metadata
- Authors
- Redondo, M. J., Rodriguez, L. M., Escalante, M., Smith, E. O., Balasubramanyam, A., & Haymond, M. W.
- Venue
- Pediatric Diabetes
- Publisher
- Hindawi Limited
- Published
- 2013-03-05
- Volume
- 14
- Issue
- 5
- Pages
- 333-340
- ISSN
- 1399-543X (ISSN-L)
- OpenAlex
- W1534645360
- Cited by
- 36
- References
- 6
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis: Forms of pediatric diabetes. https://app.cochat.ai/papers/10.1111/pedi.12022
- The paper
- Redondo, M. J., Rodriguez, L. M., Escalante, M., Smith, E. O., Balasubramanyam, A., & Haymond, M. W. (2013). Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis: Forms of pediatric diabetes. Pediatric Diabetes. https://doi.org/10.1111/pedi.12022
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.